Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,570 | -6,655 | -3,248 | -31,179 | -12,695 |
| Depreciation Amortization | 2,822 | 1,891 | 948 | 5,730 | 3,722 |
| Accounts receivable | -382 | -9 | -16 | 862 | 857 |
| Accounts payable and accrued liabilities | 802 | 817 | -18 | 2,710 | 2,107 |
| Other Working Capital | 6,844 | 2,861 | 834 | 7,862 | 3,919 |
| Other Operating Activity | 1,602 | 63 | 165 | 11,760 | 75 |
| Operating Cash Flow | $-882 | $-1,032 | $-1,335 | $-2,254 | $-2,016 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -68 | -5 | -7 | -4,328 | -2,919 |
| Net Acquisitions | N/A | N/A | N/A | -138 | -135 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,131 | -1,131 |
| Other Investing Activity | 0 | 0 | 0 | -695 | -717 |
| Investing Cash Flow | $-68 | $-5 | $-7 | $-5,161 | $-3,770 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,834 | 1,585 | 1,598 | 9,416 | 7,283 |
| Debt Repayment | -731 | -532 | -320 | -3,903 | -3,002 |
| Common Stock Issued | N/A | N/A | N/A | 658 | 556 |
| Other Financing Activity | -55 | 0 | 0 | -124 | -64 |
| Financing Cash Flow | $1,048 | $1,053 | $1,278 | $6,046 | $4,773 |
| Beginning Cash Position | 86 | 86 | 86 | 1,455 | 1,455 |
| End Cash Position | 183 | 101 | 22 | 86 | 442 |
| Net Cash Flow | $98 | $16 | $-64 | $-1,369 | $-1,013 |
| Free Cash Flow | |||||
| Operating Cash Flow | -882 | -1,032 | -1,335 | -2,254 | -2,016 |
| Capital Expenditure | -68 | -5 | -7 | -4,328 | -2,919 |
| Free Cash Flow | -950 | -1,037 | -1,341 | -6,582 | -4,935 |